Skip to content
10-Q

Quarterly Report

Summit Therapeutics Inc. SMMT

0001599298-25-000126

← back to feed
Filed
Aug 11, 2025 12:00 AM ET
Period of report
Restated figures. One or more values in this filing restate previously reported amounts.

On SEC.gov

Financials in this filing

Metric Period Value
Shares Outstanding Q2 2025 · Aug 5, 2025 742.85M sh
Shares Diluted Q2 2025 · Jun 30, 2025 742.62M sh
Shares Diluted Q2 2025 · Jun 30, 2025 740.36M sh
Shares Diluted Q2 2025 · Jun 30, 2024 707.9M sh
Shares Diluted Q2 2025 · Jun 30, 2024 704.84M sh
Capex Q2 2025 · Jun 30, 2025 $422K
Capex Q2 2025 · Jun 30, 2024 $67K
Operating Cash Flow Q2 2025 · Jun 30, 2025 −$127.91M
Operating Cash Flow Q2 2025 · Jun 30, 2024 −$63.14M
Short Term Investments Q2 2025 · Jun 30, 2025 $0
Short Term Investments Q2 2025 · Dec 31, 2024 $307.49M
Cash And Equivalents Q2 2025 · Jun 30, 2025 $297.87M
Cash And Equivalents Q2 2025 · Dec 31, 2024 $104.86M
Cash And Equivalents Q2 2025 · Jun 30, 2024 $28.43M
Stockholders Equity Q2 2025 · Jun 30, 2025 $259.44M
Stockholders Equity Q2 2025 · Mar 31, 2025 $344.33M
Stockholders Equity Q2 2025 · Dec 31, 2024 $388.75M
Stockholders Equity Q2 2025 · Jun 30, 2024 $195.08M
Stockholders Equity Q2 2025 · Mar 31, 2024 $44.21M
Stockholders Equity Q2 2025 · Dec 31, 2023 $77.69M
Current Liabilities Q2 2025 · Jun 30, 2025 $60.33M
Current Liabilities Q2 2025 · Dec 31, 2024 $41.73M
Total Liabilities Q2 2025 · Jun 30, 2025 $64.6M
Total Liabilities Q2 2025 · Dec 31, 2024 $46.81M
Current Assets Q2 2025 · Jun 30, 2025 $309.24M
Current Assets Q2 2025 · Dec 31, 2024 $423.75M
Total Assets Q2 2025 · Jun 30, 2025 $324.04M
Total Assets Q2 2025 · Dec 31, 2024 $435.56M
Eps Diluted Q2 2025 · Jun 30, 2025 −$0.76
Eps Diluted Q2 2025 · Jun 30, 2025 −$0.85
Eps Diluted Q2 2025 · Jun 30, 2024 −$0.09
Eps Diluted Q2 2025 · Jun 30, 2024 −$0.15
Eps Basic Q2 2025 · Jun 30, 2025 −$0.76
Eps Basic Q2 2025 · Jun 30, 2025 −$0.85
Eps Basic Q2 2025 · Jun 30, 2024 −$0.09
Eps Basic Q2 2025 · Jun 30, 2024 −$0.15
Sga Expense Q2 2025 · Jun 30, 2025 $360.42M
Sga Expense Q2 2025 · Jun 30, 2025 $376M
Sga Expense restated Q2 2025 · Jun 30, 2024 $13.81M
Sga Expense restated Q2 2025 · Jun 30, 2024 $25.33M
Net Income Q2 2025 · Jun 30, 2025 −$565.71M
Net Income Q2 2025 · Jun 30, 2025 −$628.62M
Net Income Q2 2025 · Mar 31, 2025 −$62.91M
Net Income Q2 2025 · Jun 30, 2024 −$60.39M
Net Income Q2 2025 · Jun 30, 2024 −$103.86M
Net Income Q2 2025 · Mar 31, 2024 −$43.47M